MedTrace Logo

Effects of Sevoflurane and Propofol on Light Flashed Evoked Pupillometry

NCT01219569 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2015-04-24

No results posted yet for this study

Summary

This is a study to focus on the feasibility of using a monitor which may signal loss of visual function intraoperatively.

Conditions

Interventions

DRUG

propofol

Propofol infusion 120 and 160 mcg/kg/min in random sequence during the operative procedure

DRUG

Sevoflurane

sevoflurane 1.5% and 2.5% end tidal in random sequence

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Geordie P. Grant, MD · Rutgers, The State University of New Jersey

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01219569 on ClinicalTrials.gov